Keep away from or Use Alternate Drug. Coadministration of apalutamide, a strong CYP3A4 inducer, with medications that are CYP3A4 substrates can lead to decrease publicity to these drugs. Prevent or substitute One more drug for these drugs when probable. Appraise for loss of therapeutic impact if medication has to be coadministered. Modify dose In a